Total Payments
$7,172
2024 Payments
$1,100
Companies
44
Transactions
394
Medicare Patients
5,604
Medicare Billing
$734,784
Payment Breakdown by Category
Food & Beverage$7,145 (99.6%)
Education$26.70 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,145 | 392 | 99.6% |
| Education | $26.70 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $823.23 | 47 | $0 (2024) |
| ABIOMED | $632.19 | 11 | $0 (2024) |
| PFIZER INC. | $497.11 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $494.82 | 28 | $0 (2024) |
| Abbott Laboratories | $461.03 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $450.10 | 24 | $0 (2024) |
| Amgen Inc. | $429.79 | 31 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $402.19 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $298.48 | 21 | $0 (2024) |
| Medtronic Vascular, Inc. | $272.92 | 20 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,100 | 49 | Merck Sharp & Dohme LLC ($174.00) |
| 2023 | $845.15 | 43 | PFIZER INC. ($210.01) |
| 2022 | $1,018 | 51 | PFIZER INC. ($156.17) |
| 2021 | $917.08 | 52 | Novartis Pharmaceuticals Corporation ($175.07) |
| 2020 | $626.77 | 42 | Boston Scientific Corporation ($131.83) |
| 2019 | $443.27 | 29 | SANOFI-AVENTIS U.S. LLC ($71.79) |
| 2018 | $956.35 | 62 | Novartis Pharmaceuticals Corporation ($135.34) |
| 2017 | $1,265 | 66 | ABIOMED ($284.52) |
All Payment Transactions
394 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $36.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Cardiology | ||||||
| 09/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardiology | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/23/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiology | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: DIABETES | ||||||
| 07/09/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Vascular | ||||||
| 07/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/27/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Cardiology | ||||||
| 06/26/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Vascular | ||||||
| 06/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/05/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: Medical Device | ||||||
| 05/29/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,272 | 1,710 | $479,806 | $153,420 |
| 2022 | 21 | 1,297 | 1,726 | $561,536 | $188,914 |
| 2021 | 22 | 1,468 | 1,960 | $572,911 | $199,393 |
| 2020 | 22 | 1,567 | 2,120 | $585,732 | $193,057 |
Total Patients
5,604
Total Services
7,516
Medicare Billing
$734,784
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 287 | 512 | $118,272 | $45,435 | 38.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 264 | 268 | $123,996 | $36,623 | 29.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 37 | 37 | $41,107 | $12,828 | 31.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 91 | 154 | $23,870 | $9,210 | 38.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 57 | $24,738 | $7,720 | 31.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 37 | 152 | $18,240 | $6,331 | 34.7% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 37 | 38 | $8,687 | $5,878 | 67.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 13 | 14 | $17,920 | $5,744 | 32.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 29 | 29 | $17,400 | $5,199 | 29.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 88 | 88 | $19,624 | $4,499 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $15,620 | $4,076 | 26.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 28 | $6,244 | $2,601 | 41.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 19 | 19 | $7,685 | $2,322 | 30.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 45 | 46 | $9,016 | $2,187 | 24.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,540 | $1,217 | 34.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 105 | 127 | $15,309 | $712.32 | 4.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 45 | 46 | $6,900 | $442.06 | 6.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 39 | $1,638 | $395.85 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 239 | 425 | $98,175 | $38,987 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 253 | 256 | $117,848 | $37,262 | 31.6% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 12 | 12 | $29,880 | $12,826 | 42.9% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2022 | 11 | 14 | $52,640 | $12,538 | 23.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2022 | 12 | 12 | $14,400 | $10,891 | 75.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 64 | 66 | $28,644 | $9,985 | 34.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 92 | 172 | $26,660 | $9,309 | 34.9% |
About Dr. Amit Prasad, MD
Dr. Amit Prasad, MD is a Cardiovascular Disease healthcare provider based in Burleson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104036185.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Prasad, MD has received a total of $7,172 in payments from pharmaceutical and medical device companies, with $1,100 received in 2024. These payments were reported across 394 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,145).
As a Medicare-enrolled provider, Prasad has provided services to 5,604 Medicare beneficiaries, totaling 7,516 services with total Medicare billing of $734,784. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Burleson, TX
- Active Since 05/22/2007
- Last Updated 01/27/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1104036185
Products in Payments
- ENTRESTO (Drug) $721.01
- Impella (Device) $632.19
- VERQUVO (Drug) $494.82
- ELIQUIS (Drug) $319.37
- XARELTO (Drug) $298.48
- BRILINTA (Drug) $245.52
- MULTAQ (Drug) $241.93
- Corlanor (Drug) $234.78
- VYNDAQEL (Drug) $232.14
- Repatha (Biological) $195.01
- Vascepa (Drug) $185.10
- FARXIGA (Drug) $181.11
- NEXLETOL (Drug) $170.34
- Arcalyst (Drug) $166.77
- PRALUENT (Drug) $160.26
- Xience Alpine cornary stent system (Device) $145.33
- KENGREAL (Drug) $126.49
- Resolute (Device) $122.95
- ZILVER PTX (Device) $104.74
- LEQVIO (Drug) $102.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Burleson
Ahmed Selim, Md, Ms, MD, MS
Cardiovascular Disease — Payments: $123,346
Cardiovascular Disease $123,346
Alvaro Rios, M.d, M.D
Cardiovascular Disease — Payments: $8,922
Cardiovascular Disease $8,922
Dr. Naginder Sharma, Md, MD
Cardiovascular Disease — Payments: $1,520
Cardiovascular Disease $1,520
Dr. Praveen Tamirisa, Md, MD
Cardiovascular Disease — Payments: $340.95
Cardiovascular Disease $340.95